A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Participants

Cardiometabolic profile: Systolic blood pressure at baseline

Millimetres of mercury (mmHg).

Time frame: At baseline: Measurement at the index date or, if unavailable, the closest measurement within the 12 months prior to the index date

Cardiometabolic profile: Waist circumference at baseline

Measured in centimetre (cm).

Time frame: At baseline: Measurement at the index date or, if unavailable, the closest measurement within the 12 months prior to the index date

Cardiometabolic profile: Hip circumference at baseline

Measured in cm.

Time frame: At baseline: Measurement at the index date or, if unavailable, the closest measurement within the 12 months prior to the index date

Cardiometabolic profile: Height at baseline

Measured in cm.

Time frame: At baseline: Measurement at the index date or, if unavailable, the closest measurement within the 12 months prior to the index date

Cardiometabolic profile: Weight at baseline

Measured in kilogram (kg).

Time frame: At baseline: Measurement at the index date or, if unavailable, the closest measurement within the 12 months prior to the index date

Cardiometabolic profile: Total cholesterol at baseline

Measured in millimoles per liter (mmol/L).

Time frame: At baseline: Measurement at the index date or, if unavailable, the closest measurement within the 12 months prior to the index date

Cardiometabolic profile: High-density lipoprotein cholesterol (HDL-C) at baseline

Measured in mmol/L.

Time frame: At baseline: Measurement at the index date or, if unavailable, the closest measurement within the 12 months prior to the index date

Cardiometabolic profile: Low-density lipoprotein cholesterol (LDL-C) at baseline

Measured in mmol/L.

Time frame: At baseline: Measurement at the index date or, if unavailable, the closest measurement within the 12 months prior to the index date

Cardiometabolic profile: Non High-density lipoprotein cholesterol (Non-HDL-C) at baseline

Measured in mmol/L.

Time frame: At baseline: Measurement at the index date or, if unavailable, the closest measurement within the 12 months prior to the index date

Cardiometabolic profile: Triglycerides at baseline

Measured in mmol/L.

Time frame: At baseline: Measurement at the index date or, if unavailable, the closest measurement within the 12 months prior to the index date

Cardiometabolic profile: Glycated haemoglobin (HbA1c) at baseline

Measured in mmol/L.

Time frame: At baseline: Measurement at the index date or, if unavailable, the closest measurement within the 12 months prior to the index date

Cardiometabolic profile: Fasting plasma glucose (FPG) at baseline

Measured in mmol/L.

Time frame: At baseline: Measurement at the index date or, if unavailable, the closest measurement within the 12 months prior to the index date

Cardiometabolic profile: estimated glomerular filtration rate (eGFR) at baseline

Measured in mL/min/1.73m\^2.

Time frame: At baseline: Measurement at the index date or, if unavailable, the closest measurement within the 12 months prior to the index date

Cardiometabolic profile: Serum creatinine at baseline

Measured in mL/min/1.73m\^2.

Time frame: At baseline: Measurement at the index date or, if unavailable, the closest measurement within the 12 months prior to the index date

Proportion of participants classified into CVD risk categories (very high, high, moderate or low risk) - Yes/No

Measured in percentage (%) of participants.

Time frame: At baseline: Status at the index date or, if unavailable, the closest record within the 12 months prior to the index date